Overview

An Open Prospective Trial of IV Ketamine in Suicidal Adolescents

Status:
Unknown status
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
1. Investigate the safety and effectiveness of a single dose of IV Ketamine for adolescents with suicidal ideation and depression. It is hypothesize that Ketamine will be well tolerated and significantly reduce depressive symptoms and suicidal ideation. 2. Explore whether decision making as measured by the Iowa Gambling Task changes before and after Ketamine infusion. It is hypothesize that IV Ketamine infusion will significantly improve the decision making ability a measured by the Iowa Gambling Task in adolescents that are suicidal.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Nationwide Children's Hospital
Treatments:
Ketamine